Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
Besse L, Bolomsky A, Ludwig H, Hannich J, Loguinov A, Everts B, Berkers C, Pilon M, Farhan H, Vulpe C, Overkleeft H, Huber J, Ståhlman M, Borén J, Besse A, Stolze S, Sobh A, Zaal E, van der Ham A, Ruiz M, Phuyal S, Büchler L, Sathianathan M, Florea B, Driessen C. Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma. Cancer Res 2021; 81:4581-4593.
22.06.2021
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
22.06.2021
Cancer Res 2021; 81:4581-4593
Besse Lenka, Bolomsky Arnold, Ludwig Heinz, Hannich J Thomas, Loguinov Alex, Everts Bart, Berkers Celia R, Pilon Marc, Farhan Hesso, Vulpe Christopher D, Overkleeft Herman S, Huber Julia, Ståhlman Marcus, Borén Jan, Besse Andrej, Stolze Sara C, Sobh Amin, Zaal Esther A, van der Ham Alwin J, Ruiz Mario, Phuyal Santosh, Büchler Lorina, Sathianathan Marc, Florea Bogdan I, Driessen Christoph
Weiter